J
James S. Forrester
Researcher at University of California, Los Angeles
Publications - 147
Citations - 16530
James S. Forrester is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 52, co-authored 147 publications receiving 16227 citations. Previous affiliations of James S. Forrester include Memorial Hospital of South Bend & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease
TL;DR: This work reviewed the literature to estimate the pretest likelihood of disease and the sensitivity and specificity of four diagnostic tests and integrates fundamental pretest clinical descriptors with many varying test results to summarize reproducibly and meaningfully the probability of angiographic coronary-artery disease.
Journal ArticleDOI
Catheterization of the Heart in Man with Use of a Flow-Directed Balloon-Tipped Catheter
H.J.C. Swan,William Ganz,James S. Forrester,Harold S. Marcus,George A. Diamond,David W. Chonette +5 more
TL;DR: Pressures in the right side of the heart and pulmonary capillary wedge can be obtained by cardiac catheterization without the aid of fluoroscopy.
Journal ArticleDOI
A new technique for measurement of cardiac output by thermodilution in man
William Ganz,William Ganz,Roberto Donoso,Roberto Donoso,Harold S. Marcus,Harold S. Marcus,James S. Forrester,James S. Forrester,Harold J.C. Swan,Harold J.C. Swan +9 more
TL;DR: Comparison with cardiac outputs determined simultaneously by the dye-dilution technique (CODYE) in 63 measurements in 20 patients showed close agreement of the 2 methods in a range of values from 2.9 to 8.0 liters/min.
Journal ArticleDOI
Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subsets
TL;DR: The goals of prompt and effective therapy of disordered cardiac function and preservation of ischemic muscle, although far from achieved, have been greatly advanced in the past several years by the widespread use of hemodynamic monitoring.
Journal ArticleDOI
Use of sildenafil (Viagra) in patients with cardiovascular disease
Melvin D. Cheitlin,Adolph M. Hutter,Ralph G. Brindis,Peter Ganz,Sanjay Kaul,Richard O. Russell,Randall M. Zusman,James S. Forrester,Pamela S. Douglas,David P. Faxon,John D. Fisher,Raymond J. Gibbons,Jonathan L. Halperin,Judith S. Hochman,Sanjiv Kaul,William S. Weintraub,William L. Winters,Michael J. Wolk +17 more
TL;DR: It is possible that a precipitous reduction in blood pressure with nitrate use may occur over the initial 24 hours after a dose of Viagra, and for patients who experience an acute cardiac ischemic event and who have taken Viagra within the past 24 hours, administration of nitrates should be avoided.